vs
Esperion Therapeutics, Inc.（ESPR）与OXFORD INDUSTRIES INC（OXM）财务数据对比。点击上方公司名可切换其他公司
OXFORD INDUSTRIES INC的季度营收约是Esperion Therapeutics, Inc.的1.8倍（$307.3M vs $168.4M），Esperion Therapeutics, Inc.同比增速更快（143.7% vs -0.2%），过去两年Esperion Therapeutics, Inc.的营收复合增速更高（10.6% vs -3.0%）
Esperion Therapeutics, Inc.是一家上市美国药企，专注开发用于降低低密度脂蛋白胆固醇的口服小分子药物苯哌多酸，公司总部位于密歇根州安娜堡，目前核心研发管线围绕这款降脂创新药物推进，深耕血脂异常治疗领域的创新药物开发。
牛津工业公司是美国一家上市服装企业，主打高端服装及服饰产品，旗下拥有多个知名品牌，包括汤米·巴哈马、莉莉·普利策、强尼·瓦斯和萨瑟恩泰德等。
ESPR vs OXM — 直观对比
营收规模更大
OXM
是对方的1.8倍
$168.4M
营收增速更快
ESPR
高出143.9%
-0.2%
两年增速更快
ESPR
近两年复合增速
-3.0%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $168.4M | $307.3M |
| 净利润 | — | $-63.7M |
| 毛利率 | — | 60.3% |
| 营业利润率 | 50.6% | -27.7% |
| 净利率 | — | -20.7% |
| 营收同比 | 143.7% | -0.2% |
| 净利润同比 | — | -1517.6% |
| 每股收益（稀释后） | $0.32 | $-4.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ESPROXM
| Q4 25 | $168.4M | $307.3M | ||
| Q3 25 | $87.3M | $403.1M | ||
| Q2 25 | $82.4M | $392.9M | ||
| Q1 25 | $65.0M | — | ||
| Q4 24 | $69.1M | $308.0M | ||
| Q3 24 | $51.6M | $419.9M | ||
| Q2 24 | $73.8M | $398.2M | ||
| Q1 24 | $137.7M | $404.4M |
净利润ESPROXM
| Q4 25 | — | $-63.7M | ||
| Q3 25 | $-31.3M | $16.7M | ||
| Q2 25 | $-12.7M | $26.2M | ||
| Q1 25 | $-40.5M | — | ||
| Q4 24 | — | $-3.9M | ||
| Q3 24 | $-29.5M | $40.6M | ||
| Q2 24 | $-61.9M | $38.4M | ||
| Q1 24 | $61.0M | $-60.1M |
毛利率ESPROXM
| Q4 25 | — | 60.3% | ||
| Q3 25 | — | 61.4% | ||
| Q2 25 | — | 64.2% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 63.1% | ||
| Q3 24 | — | 63.1% | ||
| Q2 24 | — | 64.9% | ||
| Q1 24 | — | 60.9% |
营业利润率ESPROXM
| Q4 25 | 50.6% | -27.7% | ||
| Q3 25 | -11.4% | 6.3% | ||
| Q2 25 | 8.6% | 9.2% | ||
| Q1 25 | -34.0% | — | ||
| Q4 24 | -6.4% | -2.0% | ||
| Q3 24 | -31.0% | 12.5% | ||
| Q2 24 | 3.5% | 13.2% | ||
| Q1 24 | 52.5% | -20.1% |
净利率ESPROXM
| Q4 25 | — | -20.7% | ||
| Q3 25 | -35.9% | 4.1% | ||
| Q2 25 | -15.4% | 6.7% | ||
| Q1 25 | -62.2% | — | ||
| Q4 24 | — | -1.3% | ||
| Q3 24 | -57.2% | 9.7% | ||
| Q2 24 | -83.9% | 9.6% | ||
| Q1 24 | 44.3% | -14.9% |
每股收益（稀释后）ESPROXM
| Q4 25 | $0.32 | $-4.28 | ||
| Q3 25 | $-0.16 | $1.12 | ||
| Q2 25 | $-0.06 | $1.70 | ||
| Q1 25 | $-0.21 | — | ||
| Q4 24 | $-0.14 | $-0.25 | ||
| Q3 24 | $-0.15 | $2.57 | ||
| Q2 24 | $-0.33 | $2.42 | ||
| Q1 24 | $0.34 | $-3.72 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $167.9M | $8.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-302.0M | $528.0M |
| 总资产 | $465.9M | $1.3B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ESPROXM
| Q4 25 | $167.9M | $8.0M | ||
| Q3 25 | $92.4M | $6.9M | ||
| Q2 25 | $86.1M | $8.2M | ||
| Q1 25 | $114.6M | — | ||
| Q4 24 | $144.8M | $7.0M | ||
| Q3 24 | $144.7M | $18.4M | ||
| Q2 24 | $189.3M | $7.7M | ||
| Q1 24 | $226.6M | $7.6M |
总债务ESPROXM
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $29.0M |
股东权益ESPROXM
| Q4 25 | $-302.0M | $528.0M | ||
| Q3 25 | $-451.4M | $597.1M | ||
| Q2 25 | $-433.5M | $592.4M | ||
| Q1 25 | $-426.2M | — | ||
| Q4 24 | $-388.7M | $612.2M | ||
| Q3 24 | $-370.2M | $621.6M | ||
| Q2 24 | $-344.2M | $592.9M | ||
| Q1 24 | $-294.3M | $560.9M |
总资产ESPROXM
| Q4 25 | $465.9M | $1.3B | ||
| Q3 25 | $364.0M | $1.3B | ||
| Q2 25 | $347.1M | $1.3B | ||
| Q1 25 | $324.0M | — | ||
| Q4 24 | $343.8M | $1.2B | ||
| Q3 24 | $314.1M | $1.2B | ||
| Q2 24 | $352.3M | $1.2B | ||
| Q1 24 | $373.1M | $1.1B |
负债/权益比ESPROXM
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.05× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $45.2M | $-9.1M |
| 自由现金流经营现金流 - 资本支出 | — | $-47.9M |
| 自由现金流率自由现金流/营收 | — | -15.6% |
| 资本支出强度资本支出/营收 | 0.0% | 12.6% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-79.9M |
8季度趋势，按日历期对齐
经营现金流ESPROXM
| Q4 25 | $45.2M | $-9.1M | ||
| Q3 25 | $-4.3M | $83.5M | ||
| Q2 25 | $-31.4M | $-3.9M | ||
| Q1 25 | $-22.6M | — | ||
| Q4 24 | $-35.0M | $-18.2M | ||
| Q3 24 | $-35.3M | $88.8M | ||
| Q2 24 | $-7.2M | $32.9M | ||
| Q1 24 | $53.8M | $74.9M |
自由现金流ESPROXM
| Q4 25 | — | $-47.9M | ||
| Q3 25 | — | $52.3M | ||
| Q2 25 | — | $-27.4M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $-56.9M | ||
| Q3 24 | $-35.5M | $47.2M | ||
| Q2 24 | $-7.3M | $21.0M | ||
| Q1 24 | $53.8M | $55.3M |
自由现金流率ESPROXM
| Q4 25 | — | -15.6% | ||
| Q3 25 | — | 13.0% | ||
| Q2 25 | — | -7.0% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -18.5% | ||
| Q3 24 | -68.7% | 11.2% | ||
| Q2 24 | -9.9% | 5.3% | ||
| Q1 24 | 39.0% | 13.7% |
资本支出强度ESPROXM
| Q4 25 | 0.0% | 12.6% | ||
| Q3 25 | 0.0% | 7.7% | ||
| Q2 25 | 0.0% | 6.0% | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.0% | 12.6% | ||
| Q3 24 | 0.3% | 9.9% | ||
| Q2 24 | 0.1% | 3.0% | ||
| Q1 24 | 0.1% | 4.8% |
现金转化率ESPROXM
| Q4 25 | — | — | ||
| Q3 25 | — | 5.00× | ||
| Q2 25 | — | -0.15× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.19× | ||
| Q2 24 | — | 0.86× | ||
| Q1 24 | 0.88× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
OXM
| Sales Channel Retail | $162.9M | 53% |
| Sales Channel Wholesale | $61.3M | 20% |
| Johnny Was | $45.4M | 15% |
| Sales Channel Food And Beverage | $29.3M | 10% |
| Other Foreign Countries | $9.0M | 3% |
